Cargando…
Genetic Testing in Differentiated Thyroid Carcinoma: Indications and Clinical Implications
Differentiated thyroid cancer (DTC) is a common and diverse endocrine malignancy. In most patients DTC results in an indolent and curable disease. Nevertheless, disease recurrence rates are relatively high (10%–30%), while 5% of the patients are resistant to conventional treatment and some of these...
Autor principal: | Zolotov, Sagit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rambam Health Care Campus
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737515/ https://www.ncbi.nlm.nih.gov/pubmed/26886957 http://dx.doi.org/10.5041/RMMJ.10236 |
Ejemplares similares
-
External Beam Radiation in Differentiated Thyroid Carcinoma
por: Billan, Salem, et al.
Publicado: (2016) -
Contemporary Management of Recurrent Nodal Disease in Differentiated Thyroid Carcinoma
por: Na’ara, Shorook, et al.
Publicado: (2016) -
Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process
por: Omry-Orbach, Gal
Publicado: (2016) -
What is the Minimal Surgery for Papillary Thyroid Carcinoma?
por: Fridman, Eran, et al.
Publicado: (2016) -
A Risk-adapted Approach to Follow-up in Differentiated Thyroid Cancer
por: Tarasova, Valentina D., et al.
Publicado: (2016)